News & Events

November 3, 2021
San Diego, Calif., November 4, 2021 – Plexium Inc., (Plexium), a leading next-generation targeted protein degradation (TPD) company, today announced the appointment of experienced biopharmaceutical leader Percival Barretto-Ko as President and Chief Executive Officer and a member of the Board of Directors. Mr. Barretto-Ko joins Plexium following a sixteen-year tenure with Astellas Pharma Inc., a […]
October 7, 2021
SAN DIEGO, Oct. 5, 2021 – Plexium Inc., (Plexium), a biotech company focused on discovering and developing protein degrading therapeutics directed towards historically challenging drug targets, today announced that company management will present and host one-on-one meetings at the Solebury Trout/BMO Fall Private Company Showcase 2021. The company will present on Thursday, October 14th, 2021 at […]
January 20, 2021
Company also announces appointment of biotech veteran Mike Grey as Chairman of the Board SAN DIEGO, October 19, 2020 – Plexium Inc., a biotech company focused on discovering and developing protein degrading therapeutics directed towards historically challenging drug targets, today announced the completion of a $35M financing, led by Lux Capital and Pivotal BioVentures, with […]
October 16, 2019
Funds will help advance Plexium’s DELPhe platform to discover novel E3 ligase-modulating therapeutics to treat cancer and neurodegenerative diseases SAN DIEGO, October 17, 2019 – Plexium today announced the launch of the company with the closing of a $28 million Series A financing. The financing was led by DCVC Bio and The Column Group, with […]
October 9, 2019
Plexium CEO Swamy Vijayan to present at the North American Protein Degradation Congress in San Diego, CA on February 4-5, 2020.
October 7, 2019
Plexium CEO Swamy Vijayan to present at the Targeted Protein Degradation Summit in Boston on October 23, 2019.